SAEDNEWS: An American billionaire recently underwent a procedure that scientists liken to a "human oil change," completely replacing his blood plasma with albumin.
According to SaedNews, Bryan Johnson, a 47-year-old American billionaire, recently underwent a procedure called "Therapeutic Plasma Exchange" (TPE) and claimed that this treatment is suitable for various diseases.
According to India Today, in his recent post on the X platform, Johnson explained that this procedure, which involves removing and replacing a patient's plasma, has gained attention for its ability to manage and treat a wide range of diseases.
Plasma is the liquid part of blood that carries cells, nutrients, hormones, and waste products throughout the body. Johnson wrote: "The complete plasma exchange process removes all the plasma from my body and replaces it with albumin. The therapeutic goal is to remove toxins from my body."
Albumin is a protein produced by the liver that helps maintain fluid balance, transport nutrients, and support tissue function. This protein prevents fluid from leaking out of blood vessels and plays a crucial role in medical treatments. Low levels of albumin can indicate liver or kidney problems or malnutrition. Additionally, albumin is used in medical treatments such as replenishing lost blood volume or specific procedures like plasma exchange to promote growth and tissue repair.
Johnson previously replaced one liter of his plasma with an exact amount from his son and donated his plasma to his father. When his father received the plasma, Johnson claimed that his aging slowed by 25 years and remained in that state for six months. The billionaire revealed that the complete plasma exchange took two hours.
Complete plasma exchange is a medical procedure in which a large volume of plasma is removed from the patient's blood and replaced with donor plasma or a plasma substitute. This process helps remove harmful substances such as autoantibodies, immune complexes, and toxins from the bloodstream. Experts liken this method to a "human oil change."
Studies have shown that complete plasma exchange can impact the treatment of autoimmune diseases, neurological disorders, and blood disorders. For instance, research published by the American Society of Hematology demonstrated the effectiveness of this method in treating diseases such as myasthenia gravis, Guillain-Barré syndrome, and thrombotic thrombocytopenic purpura.
Complete plasma exchange is used in intensive care units to manage critically ill patients, showcasing its versatility and life-saving potential.
